Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Non-Current Assets (2010 - 2026)

Revvity's (RVTY) quarterly Non-Current Assets came in at $9.7 billion in Q3 2026, down 3.74% on a YoY basis from $10.1 billion in Q3 2025, and down 1.22% quarter-over-quarter from $9.9 billion in Q2 2026.

Analysis

Revvity (RVTY) Non-Current Assets (2010 - 2026) Analysis & Trends

Revvity (RVTY) has reported Non-Current Assets for 17 consecutive years, with $9.7 billion the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Non-Current Assets fell 3.74% year-over-year to $9.7 billion; the trailing twelve-month figure through Jul 2026 stood at $39.5 billion (down 2.45% YoY), and the FY2025 full-year result was $9.9 billion, down 1.14% from the prior year.
  • Non-Current Assets declined to $9.7 billion in Q3 2026 per RVTY's latest filing, from $9.9 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $12.6 billion in Q1 2022 and bottomed at $9.7 billion in Q3 2026.
  • Historically, Non-Current Assets has averaged $10.6 billion across 5 years, with a median of $10.4 billion in 2024.
  • The widest YoY moves for Non-Current Assets: up 119.52% in 2022, down 15.35% in 2022.
  • Over 5 years, Non-Current Assets stood at $10.7 billion in 2022, then declined by 1.34% to $10.6 billion in 2023, then declined by 4.93% to $10.0 billion in 2024, then fell by 1.14% to $9.9 billion in 2025, then dropped by 1.82% to $9.7 billion in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $9.7 billion, $9.9 billion, and $9.9 billion for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 89.81 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 78.99 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 9.27 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 3.82 Bn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 9.75 Bn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 1.84 Bn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 7.23 Bn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 1.75 Bn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 355.40 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 3.83 Bn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 9.75 Bn
Apr 5, 2026 9.87 Bn
Dec 28, 2025 9.93 Bn
Sep 28, 2025 10.00 Bn
Jun 29, 2025 10.13 Bn
Mar 30, 2025 10.04 Bn
Dec 29, 2024 10.04 Bn
Sep 29, 2024 10.32 Bn
Jun 30, 2024 10.27 Bn
Mar 31, 2024 10.37 Bn
Dec 31, 2023 10.56 Bn
Oct 1, 2023 10.51 Bn
Jul 2, 2023 10.70 Bn
Apr 2, 2023 10.84 Bn
Jan 1, 2023 10.84 Bn
Oct 2, 2022 10.71 Bn
Jul 3, 2022 12.08 Bn
Apr 3, 2022 12.39 Bn
Jan 2, 2022 12.56 Bn
Oct 3, 2021 12.65 Bn